Arovella Therapeutics Ltd
ASX:ALA

Watchlist Manager
Arovella Therapeutics Ltd Logo
Arovella Therapeutics Ltd
ASX:ALA
Watchlist
Price: 0.18 AUD -5.26% Market Closed
Market Cap: 189.3m AUD
Have any thoughts about
Arovella Therapeutics Ltd?
Write Note

Arovella Therapeutics Ltd
PP&E Net

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Arovella Therapeutics Ltd
PP&E Net Peer Comparison

Comparables:
MYX
NEU
BOT
PBP
VLS

Competitive PP&E Net Analysis
Latest Figures & CAGR of Competitors

Company PP&E Net CAGR 3Y CAGR 5Y CAGR 10Y
Arovella Therapeutics Ltd
ASX:ALA
PP&E Net
AU$131.1k
CAGR 3-Years
-33%
CAGR 5-Years
-19%
CAGR 10-Years
N/A
Mayne Pharma Group Ltd
ASX:MYX
PP&E Net
AU$53.3m
CAGR 3-Years
-38%
CAGR 5-Years
-26%
CAGR 10-Years
N/A
Neuren Pharmaceuticals Ltd
ASX:NEU
PP&E Net
AU$35k
CAGR 3-Years
36%
CAGR 5-Years
24%
CAGR 10-Years
2%
Botanix Pharmaceuticals Ltd
ASX:BOT
PP&E Net
AU$71.8k
CAGR 3-Years
-36%
CAGR 5-Years
43%
CAGR 10-Years
N/A
Probiotec Ltd
ASX:PBP
PP&E Net
AU$61.2m
CAGR 3-Years
19%
CAGR 5-Years
14%
CAGR 10-Years
1%
Vita Life Sciences Ltd
ASX:VLS
PP&E Net
AU$9.2m
CAGR 3-Years
4%
CAGR 5-Years
0%
CAGR 10-Years
45%

See Also

What is Arovella Therapeutics Ltd's PP&E Net?
PP&E Net
131.1k AUD

Based on the financial report for Jun 30, 2024, Arovella Therapeutics Ltd's PP&E Net amounts to 131.1k AUD.

What is Arovella Therapeutics Ltd's PP&E Net growth rate?
PP&E Net CAGR 5Y
-19%

Over the last year, the PP&E Net growth was 163%. The average annual PP&E Net growth rates for Arovella Therapeutics Ltd have been -33% over the past three years , -19% over the past five years .

Back to Top